Emerging safety issues with imatinib and other Abl tyrosine kinase inhibitors

Ehab Atallah, Hagop Kantarjian, Jorge Cortes

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Emerging safety issues with imatinib and other Abl tyrosine kinase inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences